TherapeuticsMD, Inc.

TXMD

$2.24

-0.88%

N/A-$0.02

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; ...

Historical Employee Count of TXMD

Current

Change

+0.00%

Minimum

Maximum

416

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	1	10-K	Mar 30, 2026	View
Dec 31, 2024	1	10-K	Mar 27, 2025	View
Dec 31, 2023	1	10-K	Mar 29, 2024	View
Dec 31, 2022	1	10-K	Apr 7, 2023	View
Dec 31, 2021	416	10-K	Mar 23, 2022	View

Supply Chain of TXMD

Upstream / Downstream / Proxies

Upstream

Catalent Pharma Solutions (now Novo Holdings subsidiary)API and excipient suppliers to Catalent (various)Silicone polymer and hormone API suppliers for ANNOVERA

Downstream

Mayne Pharma Group LimitedASX:MYXTheramex HQ UK LimitedKnight Therapeutics Inc.TSX:GUDAmneal Pharmaceuticals, Inc.NASDAQ:AMRXDuchesnay Inc.Population Council

Proxies

Royalty Pharma plcNASDAQ:RPRXDRI Healthcare TrustTSX:DHT.UN

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer